Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase (MMP)-2

Biomedicine and Pharmacotherapy

Volumn 62, Issue 5, 2008, Pages 297-302

  Wang, Subo ^a   Cheng, Yanna ^b   Wang, Fengshan ^b   Sun, Lirui ^b   Liu, Chunhui ^b   Chen, Guanjun ^a   Li, Yuhua ^b   Ward, S G ^c   Qu, Xianjun ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c University of Bath   (United Kingdom)

Author keywords

Matrix metalloproteinases; Migration; MMP 2; S. maindroni ink polysaccharide (SIP); Sulfated polysaccharide (SIP SII); Tumor invasion

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; POLYSACCHARIDE SULFATE;

ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL INVASION; CELL LINE; CELL MIGRATION; CUTTLEFISH; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPIELLA MAINDRONI; TUMOR CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DECAPODIFORMES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; POLYSACCHARIDES; UMBILICAL VEINS;

EID: 44349113176     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.01.018     Document Type: Article

References (28)

1. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9 (2005) 267-285
2. Shen C., Xie J., and Xu X. The components of cuttlefish (Sepiella maindroni de Rochebruns) oil. Food Chemistry 102 (2007) 210-214
3. Liu CH, Li X, Li Y, Feng Y, Wang F. Structural characterization and antimutagenic activity of a novel polysaccharide isolated from Sepiella maindroni ink. Food Chemistry, in press, doi:10.1016/j.foodchem.2008.02.026.
4. Geresh S., Manontov A., and Weinstein J. Sulfation of extracellular polysaccharides of red microalgae: preparation, characterization and properties. J Biochem Biophys Methods 50 (2002) 179-187
5. Li X.D., Wang F.S., and Song Y.S. Study on the preparation and properties of glycosaminoglycans from the ink of Sepiella maindroni de Rochebrune. Chin J Marine Drugs 100 (2004) 24-27
6. Liu J., Li X., Cheng Y.N., Cui S.X., Chen M.H., Xu W.F., et al. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil. Eur J Pharmacol 574 (2007) 1-7
7. Qu X.J., Yang J.L., Russell P.J., and Goldstein D. Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. J Urol 172 (2004) 733-738
8. Souza-Tarla C.D., Uzuelli J.A., Machado A.A., and Gerlach R.F. Tanus-Santos JE: Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 38 (2005) 410-414
9. Sumi M., Sata M., Hashimoto A., Imaizumi T., Yanaga K., Ohki T., et al. OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesis. Biomed Pharmacother 61 (2007) 209-215
10. Ha K.T., Kim J.K., Kang S.K., Kin D.W., Lee Y.C., Kim H.M., et al. Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma. Pharmacol Res 50 (2004) 279-285
11. Hossain Z., Kurihara H., Hosokawa M., and Takahashi K. Docosahexaenoic acid and eicosapentaenoic acid-enriched phosphatidylcholine liposomes enhance the permeability, transportation and uptake of phospholipids in Caco-2 cells. Mol Cell Biochem 285 (2006) 155-163
12. Fujikawa T., Shiraha H., Ueda N., Takaoka N., Kakanishi N., Matsuo N., et al. Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem 282 (2007) 8741-8748
13. Sood A.K., Bhatty R., Kamat A.A., Landen C.N., Han L., Thaker P.H., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 12 (2006) 369-375
14. Yang X., Luo P., Yang B., and He Q. Antiangiogenesis response of endothelial cells to the antitumour drug 10-methoxy-9-nitrocamptothecin. Pharmacol Res 54 (2006) 334-340
15. Garrison J.B., Shaw Y.J., Chen C.S., and Kyprianou N. Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. Cancer Res 67 (2007) 11344-11352
16. Vacca R.D., Presta M., Minischetti M., Iurlaro M., Ria R., Albini A., et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93 (1999) 3064-3073
17. Borgenström M., Wärri A., Hiilesvuo K., Käkönen R., Käkönen S., Nissinen L., et al. O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis. Semin Thromb Hemost 33 (2007) 547-556
18. Tang X., Li J., Xin X., and Geng M. A new marine-derived sulfated polysaccharide from brown alga suppresses tumor metastasis both in vitro and in vivo. Cancer Biol Ther 5 (2006) 1474-1480
19. Koyanagi S., Tanigawa N., Nakagawa H., Soeda S., and Shimeno H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65 (2003) 173-179
20. Kim M.M., and Kim S.K. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Lett 580 (2006) 2661-2666
21. Lida J., Wilhelmson K.L., Ng J., Lee P., Morrison C., Tam E., et al. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J 403 (2007) 553-563
22. Munesue S., Yoshitomi Y., Kusano Y., Koyama Y., Nishiyama A., Nakanishi H., et al. A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem 282 (2007) 28164-28174
23. Jin Y., Zhang L., Zhang M., Chen L., Cheung P.C., Qi V.E., et al. Antitumor activities of heteropolysaccharides of Poria cocos mycelia from different strains and culture media. Carbohydr Res 338 (2003) 1517-1521
24. Isnard N., Robert L., and Renard G. Effect of sulfated GAGs on the expression and activation of MMP-2 and MMP-9 in corneal and dermal explant cultures. Cell Biol Int 27 (2003) 779-784
25. Sandya S., and Sudhakaran P.R. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis. Exp Biol Med (Maywood) 232 (2007) 629-637
26. Onisto M., Slongo M.L., Gregnanin L., Gastaldi T., Carli M., and Rosolen A. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Int J Oncol 27 (2005) 791-798
27. Qu X.J., Yuan Y.X., Tian Z.G., Xu W.F., Chen M.H., Cui S.X., et al. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis. Int J Mol Med 18 (2006) 609-614
28. Isnard N., Peterszegi G., Robert A.M., and Robert L. Regulation of elastase-type endopeptidase activity, MMP-2 and MMP-9 expression and activation in human dermal fibroblasts by fucose and a fucose-rich polysaccharide. Biomed Pharmacother 56 (2002) 258-264